Pfizer/BioNTech shot more effective than Sinovac - study

Saturday, 19. June 2021 05:42

Researchers in Hong Kong have found that recipients of the Pfizer/BioNTech coronavirus vaccine have "substantially higher" levels of antibodies compared to those who have received the Chinese-made Sinovac shot, as cited by the South China Morning Post.

The results suggested that people who have been vaccinated with Sinovac against COVID-19 might need a third shot of the jab. Meanwhile, scientists have been increasingly looking into the mixing and matching of different coronavirus vaccines in order to avoid certain side effects and increase their efficacy.

The Sinovac vaccine was approved for emergency use by the World Health Organization earlier this month.

Related Links: BioNTech SEPfizer Inc.
Author:
Breaking the News / JC